Alembic Pharma gets USFDA nod for generic drug

Alembic Pharmaceuticals has received the United States Food and Drug Administration approval. The approval allows them to market Carbamazepine tablets in the US. This medication is a generic version of Tegretol Tablets. Carbamazepine tablets are anticonvulsants. They also treat pain from trigeminal neuralgia. The market size for these tablets is estimated at USD 32 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L6AQlWJ
via IFTTT